| Literature DB >> 28469611 |
Patricia Munsch-Alatossava1, Susanna Jääskeläinen1, Tapani Alatossava1, Jean-Pierrre Gauchi2.
Abstract
Antibiotic resistance has been noted to be a major and increasing human health issue. Cold storage of raw milk promotes the thriving of psychrotrophic/psychrotolerant bacteria, which are well known for their ability to produce enzymes that are frequently heat stable. However, these bacteria also carry antibiotic resistance (AR) features. In places, where no cold chain facilities are available and despite existing recommendations numerous adulterants, including antibiotics, are added to raw milk. Previously, N2 gas flushing showed real potential for hindering bacterial growth in raw milk at a storage temperature ranging from 6 to 25°C. Here, the ability of N2 gas (N) to tackle antibiotic- resistant bacteria was tested and compared to that of the activated lactoperoxidase system (HT) for three raw milk samples that were stored at 6°C for 7 days. To that end, the mesophiles and psychrotrophs that were resistant to gentamycin (G), ceftazidime (Ce), levofloxacin (L), and trimethoprim-sulfamethoxazole (TS) were enumerated. For the log10 ratio (which is defined as the bacterial counts from a certain condition divided by the counts on the corresponding control), classical Analyses of Variance (ANOVA) was performed, followed by a mean comparison with the Ryan-Einot-Gabriel-Welsch multiple range test (REGWQ). If the storage "time" factor was the major determinant of the recorded effects, cold storage alone or in combination with HT or with N promoted a sample-dependent response in consideration of the AR levels. The efficiency of N in limiting the increase in AR was highest for fresh raw milk and was judged to be equivalent to that of HT for one sample and superior to that of HT for the two other samples; moreover, compared to HT, N seemed to favor a more diverse community at 6°C that was less heavily loaded with antibiotic multi-resistance features. Our results imply that N2 gas flushing could strengthen cold storage of raw milk by tackling the bacterial spoilage potential while simultaneously hindering the increase of bacteria carrying antibiotic resistance/multi-resistance features.Entities:
Keywords: N2 gas; Ryan-Einot-Gabriel-Welsch test; antibiotic resistance (AR); cold storage; lactoperoxidase system; raw milk
Year: 2017 PMID: 28469611 PMCID: PMC5395576 DOI: 10.3389/fmicb.2017.00655
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
pH values for raw milk samples (S1 to S3), determined at initial and final stages (after 7d storage at 6°C), for the three conditions: non treated raw milk (C), activated lactoperoxidase system (HT), and N.
| S1 | 6.81 | 6.35 | 6.81 | 6.73 |
| S2 | 6.74 | 6.46 | 6.76 | 6.60 |
| S3 | 6.75 | 6.25 | 6.78 | 6.73 |
Figure 1Mesophilic (M) and psychrotrophic (P) bacterial counts (expressed in log cfu/ml) from raw milk samples S1, S2, and S3 that were stored for 7 days at 6°C (C), cold-stored while the lactoperoxidase system was activated (HT) or cold-stored while flushed with N. The colonies were enumerated on Mueller-Hinton agar plates that contained no antibiotics (“no AB”) or one of the following ABs: G (gentamycin), Ce (ceftazidime), L (levofloxacin) and TS (trimethoprim-sulfamethoxazole) (the error bars correspond to standard deviations).
Figure 2REGWQ results depicting the impact of either 3 or 7 days of storage at 6°C on mesophilic (M) and psychrotrophic (P) populations that were recovered from the raw milk samples S1, S2, and S3. Means with different letters indicate significant differences (alpha risk = 0.05).
Figure 3REGWQ results describing the overall inhibitory efficiency of HT (the activated lactoperoxidase system) and N (N. Means with the same letter are not significantly different (alpha risk = 0.05).
Ranking of the log.
| TS | 1.81 | A | no AB | 2.05 | A | |||||
| no AB | 1.60 | A | B | TS | 1.63 | A | B | |||
| Ce | 0.73 | B | C | Ce | 0.71 | A | B | C | ||
| L | 0.34 | C | L | 0.56 | B | C | ||||
| G | 0.32 | C | G | 0.01 | C | |||||
| no AB | 1.54 | A | G | 3.07 | A | |||||
| TS | 1.16 | A | no AB | 2.77 | A | |||||
| Ce | 0.75 | A | Ce | 2.12 | A | |||||
| L | 0.70 | A | L | 1.91 | A | |||||
| G | 0.67 | A | TS | 1.70 | A | |||||
| no AB | 1.44 | A | no AB | 3.78 | A | |||||
| Ce | 0.81 | A | TS | 2.03 | A | B | ||||
| G | –0.20 | B | Ce | 1.04 | B | |||||
| TS | –0.38 | B | L | 0.75 | B | |||||
| L | –0.54 | B | G | 0.42 | B | |||||
Means with the same letter are not significantly different (alpha risk = 0.05)
Figure 4REGWQ results showing the impact of the HT (the activated lactoperoxidase system) and N (N.
Factors and significant double interactions that determined the recorded effects evaluated for log.
| S1M | Time F 51.46 | <0.0001 | Treatment | <0.0001 |
| Treatment F 23.88 | <0.0001 | Time | 0.0194 | |
| AB F 6.31 | 0.0002 | |||
| S1P | Time F 198.49 | <0.0001 | Treatment | <0.0001 |
| Treatment F 13.21 | <0.0001 | Time | 0.0007 | |
| AB F 4.69 | 0.0021 | |||
| S2M | Time F 134.56 | <0.0001 | Treatment | 0.0001 |
| Treatment F 17.24 | <0.0001 | Time | 0.0159 | |
| S2P | Time F 120.87 | <0.0001 | Treatment | 0.0005 |
| Treatment F 19.56 | <0.0001 | Time | 0.0826 | |
| AB F 2.61 | 0.0431 | |||
| S3M | Time F 117.89 | <0.0001 | Time | <0.0001 |
| Treatment F 43.06 | <0.0001 | Time | <0.0001 | |
| AB F 9.22 | <0.0001 | Treatment | <0.0001 | |
| S3P | Time F 45.45 | <0.0001 | Time | 0.0033 |
| Treatment F 10.25 | 0.0001 | Treatment | 0.0010 | |
| AB F 6.44 | 0.0002 |
p value associated with the F statistic.